INS and Hepatic steatosis: Intrasubcutaneous adipose tissue injections of anti-miR-149-3p lentiviral vectors ameliorated hepatic steatosis and whole-body insulin sensitivity by increasing Prdm16 gene expression, and suppressing proinflammatory genes [20].